Role of cholecystokinin type B receptors in ultrasound induced behavior in rats

Peptides

Volumn 20, Issue 3, 1999, Pages 383-386

  Voits, M ^a   Beckett, S R G ^b   Marsden, C A ^b   Fink, H ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

CCK 4; CCK B receptor; Cholecystokinin; Defense; L 365.260; Panic; Rat; Ultrasound

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; CHOLECYSTOKININ B RECEPTOR; RECEPTOR SUBTYPE; TETRAGASTRIN;

ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PANIC; PRIORITY JOURNAL; RAT; ULTRASOUND;

ANIMALS; BENZODIAZEPINONES; DRUG ANTAGONISM; ESCAPE REACTION; HUMANS; MALE; PHENYLUREA COMPOUNDS; RATS; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, CHOLECYSTOKININ; SOUND; TETRAGASTRIN;

EID: 0032874362     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(99)00046-7     Document Type: Article

References (20)

1. Beckett S.R.G., Aspley S., Graham M., Marsden C.A. Pharmacological manipulation of ultrasound induced defense behavior in the rat. Psychopharmacology. 127:1996;384-390.
2. Beckett S.R.G., Duxon M.S., Aspley S., Marsden C.A. Central c-fos expression following 20 kHz ultrasound induced defence behavior in the rat. Brain Res Bull. 42:1997;421-426.
3. Beckett S.R.G., Lawrence A.J., Marsden C.A., Marshall P.W. Attenuation of a chemically induced defence response by 5-HT-1 receptor agonists administered into the periaqueductal grey. Psychopharmacology. 108:1992;110-114.
4. Bradwejn J., Koszycki D., Shirqui C. Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings. Arch Gen Psychiatry. 48:1991;603-610.
5. Bradwejn J., Koszycki D., Couetoux du Tertre A., van Megen H., den Boer J., Westenberg H., Annable L. The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by l-365.260, a central cholecystokinin receptor antagonist, in patients with panic disorder. Arch Gen Psychiatry. 51:1994;486-493.
6. Commissaris R.L., Beckett S.R.G., Marsden C.A. The effects of anti-seizure treatments on the behavioral effects of ultrasound presentation in Lister hooded rats (abstract). Soc Neurosci. 23:1997;988.
7. De Montigny C. Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Arch Gen Psych. 46:1989;511-517.
8. Deakin J.F.W., Graeff F.G. 5-HT and mechanisms of defence. J Psychopharmacol. 5:1991;305-315.
9. Graham M., Marsden C.A. The effect of repeated administration of 20 kHz ultrasound on seizure production in rats (abstract). Soc Neurosci. 23:1997;988.
10. Griebel G., Perrault G., Sanger D.J. CCK receptor antagonists in animal models of anxiety comparison between exploration tests, conflict procedures and a model based on defensive behaviors . Behav Pharmacol. 8:1997;549-560.
11. Hilton S.M., Redfern W.S. A search for brainstem cell groups integrating the defence reaction in the rat. J Physiol (Lond). 378:1986;213-228.
12. Kadar T., Pesti A., Penke B., Telegdy G. Inhibition of seizures induced by picrotoxin and electroshock by cholecystokinin octapeptides and their fragments in rats after intracerebroventricular administration. Neuropharmacology. 23:1984;955-961.
13. Koella W.P. Animal experimental methods in the study of antiepileptic drugs. Frey H.H., Janz P. Handbook of experimental pharmacology, vol. 74. Antiepileptic drugs. 1985;283-339 Springer-Verlag, Berlin.
14. Kramer M.S., Cutler N.R., Ballenger J.C., Patterson W.M., Mendels J., Chenault A., Shrivastava R., Matzura-Wolfe D., Lines C., Reines S. A placebo-controlled trial of l-365.260, a CCK-B antagonist, in panic disorder. Biol Psych. 37:1995;462-466.
15. Miczek K.A., Weerts E.M., Vivian J.A., Barros H.M. Aggression, anxiety and vocalizations in animals GABA-A and 5-HT anxiolytics . Psychopharmacology. 121:1995;38-56.
16. Mongeau R., Marsden C.A. Effect of central and peripheral administration of cholecystokinin-tetrapeptide on panic-like reactions induced by stimulation of the dorsal periaqueductal grey area in the rat. Biol Psychiatry. 42:1997;335-344.
17. Rex A., Barth T., Voigt J.P., Domeney A.M., Fink H. Effects of cholecystokinin tetrapeptide and sulfated cholecystokinin octapeptide in rat models of anxiety. Neurosci Lett. 172:1994;139-142.
18. Rodgers R.J., Johnson N.J.T. Cholecystokinin and anxiety promises and pitfalls . Crit Rev Neurobiol. 9:1996;345-369.
19. Van Megen H.J.G.M., Westenberg H.G.M., den Boer J.A. Effect of the cholecystokinin-B receptor antagonist l-365.260 on lactate-induced panic attacks in panic disorder patients. Biol Psychiatry. 40:1996;804-806.
20. Zhang L.X., Zhou Y., Du Y., Han J.S. Effect of CCK-8 on audiogenic epileptic seizure in P77PMC rats. Neuropeptides. 25:1993;73-76.